End-stage Hypertrophic Cardiomyopathy with Advanced Heart Failure in Patients Carrying MYH7 R453 Variants: A Case Series.


Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
01 Nov 2023
Historique:
medline: 3 11 2023
pubmed: 23 3 2023
entrez: 22 3 2023
Statut: ppublish

Résumé

The MYH7 R453 variant has been identified in inherited hypertrophic cardiomyopathy (HCM) and is associated with sudden death and a poor prognosis. The detailed clinical course of HCM with the MYH7 R453 variant, from a preserved to a reduced left ventricular ejection fraction, has not been reported. We identified the MYH7 R453C and R453H variants in three patients who progressively developed advanced heart failure requiring circulatory support and summarized the clinical course and echocardiographic parameters of these patients over the years. Because of the rapid disease progression, we consider genetic screening for patients with HCM imperative for future prognosis stratification.

Identifiants

pubmed: 36948619
doi: 10.2169/internalmedicine.1497-22
pmc: PMC10686745
doi:

Substances chimiques

MYH7 protein, human 0
Myosin Heavy Chains EC 3.6.4.1
Cardiac Myosins EC 3.6.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3167-3173

Références

Circulation. 2020 Apr 28;141(17):1371-1383
pubmed: 32228044
N Engl J Med. 2008 May 1;358(18):1899-908
pubmed: 18403758
Science. 2016 Feb 5;351(6273):617-21
pubmed: 26912705
BMC Med Genet. 2012 Mar 19;13:17
pubmed: 22429680
Nat Rev Cardiol. 2020 May;17(5):286-297
pubmed: 31605094
Circulation. 2018 Oct 2;138(14):1387-1398
pubmed: 30297972
Intern Med. 2022 Jul 1;61(13):1987-1993
pubmed: 34924461
Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12607-12
pubmed: 23798412
J Am Coll Cardiol. 2011 Aug 16;58(8):839-48
pubmed: 21835320
Am J Hum Genet. 1993 Dec;53(6):1180-5
pubmed: 8250038
Nat Biomed Eng. 2019 Feb;3(2):147-157
pubmed: 30923642
Nat Rev Cardiol. 2016 Nov;13(11):651-675
pubmed: 27681577
Curr Cardiol Rep. 2020 Jan 24;22(2):8
pubmed: 31980956
Circ J. 2021 Aug 25;85(9):1590-1689
pubmed: 34305070
Circ Res. 2017 Sep 15;121(7):749-770
pubmed: 28912181
Circulation. 2006 Jul 18;114(3):216-25
pubmed: 16831987
Circulation. 2010 Dec 7;122(23):2441-9; discussion 2450
pubmed: 21135372
N Engl J Med. 1992 Apr 23;326(17):1108-14
pubmed: 1552912
J Biol Chem. 2014 Feb 21;289(8):5158-67
pubmed: 24344137
J Am Coll Cardiol. 2022 Oct 11;80(15):1447-1461
pubmed: 36007715
Eur Heart J. 2014 Oct 14;35(39):2733-79
pubmed: 25173338
Hum Genet. 1996 May;97(5):585-90
pubmed: 8655135
Clin Genet. 2018 Feb;93(2):310-319
pubmed: 29053178
Genet Med. 2015 Nov;17(11):880-8
pubmed: 25611685
J Am Coll Cardiol. 2002 Jun 19;39(12):2042-8
pubmed: 12084606
Lancet. 2020 Sep 12;396(10253):759-769
pubmed: 32871100
Exp Clin Cardiol. 2001 Winter;6(4):223-7
pubmed: 20428263

Auteurs

Susumu Naito (S)

Faculty of Medicine, Osaka University, Japan.

Shuichiro Higo (S)

Department of Medical Therapeutics for Heart Failure, Osaka University Graduate School of Medicine, Japan.
Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Japan.

Satoshi Kameda (S)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Japan.

Shou Ogawa (S)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Japan.

Tomoka Tabata (T)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Japan.

Yasuhiro Akazawa (Y)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Japan.

Daisuke Nakamura (D)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Japan.

Kei Nakamoto (K)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Japan.

Fusako Sera (F)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Japan.

Yuki Kuramoto (Y)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Japan.

Yoshihiro Asano (Y)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Japan.
Clinical Genetic Counseling Room, National Cerebral and Cardiovascular Center, Japan.

Shungo Hikoso (S)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Japan.

Shigeru Miyagawa (S)

Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Japan.

Yasushi Sakata (Y)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH